(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

GLYCOEXPRESS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

GLYCOEXPRESS

ST13

US500000079068784

Classe

1, 5, 42

Pedido

79068784

Registro

3991708

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

71

Atualização mais recente

06/11/2022

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 42

Data de depósito

27/11/2008

Data de registro

12/07/2011

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

28/01/2022

Última transação

28/01/2022

Escritório responsável

United States Patent and Trademark Office

Código da situação

709

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

13125 Berlin, DE

Examinador

LEE, DEBRA ANN

Unidade examinadora

M70

Titulares e representantes

Titulares

Glycotope GmbH
Glycotope GmbH

Representantes

GARY D. KRUGMAN SUGHRUE MION, PLLC

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemicals used in industryscience and photographyas well as in agriculturehorticulture and forestryexcept fungicidesherbicidesinsecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; fertilizing preparations; fire extinguishing compositions; tempering and soldering chemicals; chemical substances for fermenting and preserving food stuffs; tanning agents for use in the manufacture of leather; adhesives used in industry; bacteria and cell preparations and elementsfragmentsfractions and lysates thereofexcept for medical or veterinary purposesfor use in protein productionfood manufacturingscientific researchwaste water treatmentbacteria and cell preparations for use in expression of engineered or glycosylated proteins and peptides; preparations containing bacteria and cellsexcept for medical or veterinary purposesfor use in protein productionfood manufacturingscientific researchwaste water treatment; biological preparations for laboratoriesexcept for medical or veterinary purposesfor use in bacterial and cell engineeringcultivationharvestingprotein production; chemical preparations for analysis in laboratoriespreparations for proteinpeptideengineered proteins and peptidesglycoproteinsglycosylationantibody or antigen analysispreparations comprising antibody reagents used for the detection of antigens; chemical preparations for scientific purposes; chemical reagents except for medical or veterinary purposes and biological reagents in the nature of reagents for use in protein productionbacterial and cell engineeringcultivation and harvestingprobes for detecting and analyzing molecules in protein or nucleotide arraysexcept for medical or veterinary purposes; diagnostic preparationsexcept for medical or veterinary purposes; enzymesproteins and respective preparations for industrial purposesengineered proteinsglycosylated proteinsantibodiesenzymes for use in glycosylationenzyme substratesproteins used in the manufacture of cosmeticsbeveragesfood products and food supplements; ferments for chemical purposesyeastbacteriummoldenzymethat causes fermentation; in-vitro diagnostic preparationsother than for medical purposes; carbohydrates used as an ingredient or as an integral component in food or nutraceuticals; cultures of microorganisms and cells and elementsfragmentsfractions and lysates thereofother than for medical or veterinary purposescultures of microorganisms and cells other than for medical and veterinary usemicroorganism or cell cultures for use in protein productionfood manufacturingscientific researchwaste water treatmentcultures of microorganisms or cells for use in expression of glycosylated proteins and peptides; gene expression systems for proteins and peptidesparticularly on the basis of cellsparticularly human cells and microorganismsgene expression systems comprising biochemicalsassaysreagents for use in manufacturing engineered or glycosylated proteins or peptides and for scientific researchgene expression systems comprising biochemicalsassays and reagents with optimized glycosylation activity for use in manufacturing proteins or peptidesin particular engineered or glycosylated proteins or peptidesfor scientific research; milk ferments for medical research purposes

Classe 5

Pharmaceutical and veterinary preparations for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; sanitary preparations for medical purposes; dietetic foods adapted for medical use; food for babies; medical plasters; materials for medical dressings; disinfectants for sanitary purposes; preparations for destroying vermin; fungicidesherbicides; adjuvants for medical purposes; medicines for human and veterinary purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; biological preparations for medical purposes; dietetic food adapted for medical purposes; enzymeproteinsantibodiescellsmicroorganisms as well as fragmentsfractionselements and lysates thereof for medical purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicineas nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; vaccines; carbohydrates for medical purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; cultures of microorganisms for medical or veterinary purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; cultures of human cells for medical or veterinary purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; medical drinks for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; microorganismscells and preparations containing elementsfragmentsfractions and lysates of microorganisms or cells for medical and veterinary purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; biological therapeuticstherapeutics containing cellsmicroorganismsproteinsglycoproteinspeptidesglycopeptides or modified or conjugated versions thereof for use in the prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; milk ferments for pharmaceutical purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; nutritional additives and nutritional supplement additives for medical purposes for use in foods and dietary supplements for human consumption; nutrients for medical purposes for human or animalsnutritional additives in the nature of enzymesproteinsantibodiescellsmicroorganisms as well as fragmentsfractionselements and lysates thereof; sugar and carbohydrates for medical purposestherapeutically and prophylactically active sugar and carbohydratesdietetic sugar and carbohydratessugar and carbohydrate replacements

Classe 42

Scientific and technological servicesbacteria and cell engineering servicesbacteria and cell cultivation and harvesting servicesresearch and development related to protein productionglycosylationoptimization of proteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting; research and design services in the field of biotechnologyprotein productionglycosylationoptimization of proteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting; industrial analysis and research services in the field of biotechnologyprotein productionglycosylationproteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting; design and development of computer hardware and software; biological research; services of a chemical or biological laboratory; technical surveysconducting biotechnology surveyspharmacology surveys; conducting scientific surveys in the field of biotechnologybacterial and cell engineeringprotein productionglycosylation; research and development in the field of bacteriologycytologyantibody technologychemistryimmunologycosmetics of expression systems in the nature of glycosylation of proteinspeptidesantibodies and enzymesparticularly for proteins and peptides; quality control; research and development of new products and technologies in the field of biotechnologyprotein productionglycosylationproteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting for others; technology and scientific consultancy in the field of biotechnologyprotein productionglycosylationproteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting; research and development in the field of glycomicsexpression systems in the nature of glycosylation of proteinspeptidesantibodies and enzymesdevelopment and improvement of cellscell lines and microorganismsantibody-engineeringoptimized biological therapeutics; nutraceuticalsfood and nutritional supplements; researchquality controltechnology consultancy and product development in the field of proteinsantibodiesmicroorganisms and cells; research and development in the field of microorganisms and cells

Publicações

Histórico de despachos e eventos da marca no USPTO.

71 publicações encontradas

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

06/11/2022

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

06/10/2022

INPC

INVALIDATION PROCESSED

06/10/2022

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

28/09/2022

C71T

CANCELLED SECTION 71

28/01/2022

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

12/07/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

16/12/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

16/12/2019

RNWL

INTERNATIONAL REGISTRATION RENEWED

27/12/2018

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

19/10/2018

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

13/09/2018

INPC

INVALIDATION PROCESSED

13/09/2018

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

03/09/2018

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

27/07/2017

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

27/07/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

22/07/2017

ES75

TEAS SECTION 71 & 15 RECEIVED

06/07/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

14/12/2013

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/03/2013

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/01/2012

FIMP

FINAL DISPOSITION PROCESSED

05/01/2012

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/10/2011

R.PR

REGISTERED-PRINCIPAL REGISTER

12/07/2011

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

26/04/2011

PUBO

PUBLISHED FOR OPPOSITION

26/04/2011

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

23/04/2011

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

06/04/2011

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

06/04/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

22/03/2011

EXPT

EXPARTE APPEAL TERMINATED

22/03/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

21/03/2011

XAEC

EXAMINER'S AMENDMENT ENTERED

21/03/2011

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

21/03/2011

GNEA

EXAMINERS AMENDMENT E-MAILED

21/03/2011

CNEA

EXAMINERS AMENDMENT -WRITTEN

21/03/2011

GEA1

NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED

11/03/2011

GECD

ACTION DENYING REQ FOR RECON E-MAILED

11/03/2011

CNCF

ACTION CONTINUING FINAL - COMPLETED

11/03/2011

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

05/03/2011

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

17/02/2011

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

17/02/2011

EXPI

EX PARTE APPEAL-INSTITUTED

14/02/2011

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

14/02/2011

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

14/02/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/02/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/02/2011

ALIE

ASSIGNED TO LIE

31/01/2011

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

31/01/2011

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

28/10/2010

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

28/10/2010

CNFR

FINAL REFUSAL MAILED

12/08/2010

CNFR

FINAL REFUSAL WRITTEN

11/08/2010

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

27/07/2010

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

21/01/2010

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

21/01/2010

LIMS

LIMITATION OF GOODS/SERVICES FROM IB ENTERED

05/01/2010

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

22/12/2009

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

22/12/2009

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

30/11/2009

ATRV

ATTORNEY REVIEW COMPLETED

17/10/2009

CREV

CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED

25/09/2009

RFNP

REFUSAL PROCESSED BY IB

19/09/2009

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

18/09/2009

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

26/06/2009

RFRR

REFUSAL PROCESSED BY MPU

26/06/2009

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

26/06/2009

CNRT

NON-FINAL ACTION WRITTEN

25/06/2009

MAFR

APPLICATION FILING RECEIPT MAILED

23/06/2009

DOCK

ASSIGNED TO EXAMINER

19/06/2009

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

19/06/2009

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

18/06/2009

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace GLYCOEXPRESS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.